First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia Patients

Summary

The purpose of this study is to examine the safety, tolerability and the way the body handles various single and multiple doses of ARC19499 in patients with hemophilia.

Timeline

Start

2010-09-15

Primary completion

2011-12-28

Completion

2011-12-28

Drugs

Indications